Insights on the Poultry Vaccines Global Market to 2028 - Featuring Zoetis, Ceva Sante Animale and BIOVAC Among Others

News provided by

Jun 30, 2022, 08:15 ET

DUBLIN, June 30, 2022 /PRNewswire/ -- The "Global Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Technology, Dosage Form, Disease, Route of Administration, End User" report has been added to ResearchAndMarkets.com's offering.

The global poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

The COVID-19 pandemic and the associated lockdown for a long period led to significant adversities in different sectors, including the agriculture and other allied sub-sectors in India and several other countries.

The members of the North American Meat Institute process the great majority of beef, pig, lamb, and poultry produced in the US, which is required to make the safest and finest quality meat and poultry products. According to federal guidance approved by the Advisory Committee on Immunization Priority (ACIP) of the Centers for Disease Control (CDC), frontline meat and poultry workers should be the next priority for COVID-19 vaccination, after the healthcare workers. Members of the meat institute have distributed numerous pieces of personal protective equipment, implemented health and temperature screening, drastically altered facilities, conducted testing, provided paid preemptive leaves for high-risk and quarantined employees, and improved air sanitation and ventilation. Due to these safety measures, COVID-19 infection rates are now more than 8-times lower among meat and poultry workers than in the general population. However, limited processing capacity for poultry has negatively impacted the distribution and retail of animal products in the US.

The shutdown of teaching and training institutes, competition and event venues, tourist places, and trade and sales facilities has led to a drop in demand for poultry vaccines. Chickens are not sensitive to SARS-CoV-2 infection, i.e., COVID-19. Nonetheless, the COVID-19 pandemic had an impact on poultry consumption, transportation, and farming economics. Stockholders, veterinarians, farmers, and the entire poultry production chain partners need to be more involved in the current situation to fulfill consumer demands and ensure sustainable agriculture. According to a recent report prepared by P W Cargill, Merial Avian Business Unit UK and Joey Johnston, Merial Avian Business Unit, USA 2021, although the pandemic disrupted the poultry industry in Europe in 2020, it is expected to resurge in 2021.

Amid the COVID-19 crisis, in June 2020, the Government of Japan (GOJ) declared a state of emergency and asked people to stay home. During these lockdowns, the demand for poultry meat gone down due to the shuttering of restaurants. According to Investment Information and Credit Rating Agency of India Limited, the poultry industry in India suffered great losses during the recent lockdown with Q4 FY2020 being the worst quarter in 2020. The industry incurred huge losses due to a sharp decline in sales, demand, realization, and profitability. Rumors spread on social media about poultry birds being possible vectors of SARS-CoV-2 further hampered the demand for poultry products. In January 2021, the largest bird flu outbreak in years hit chicken farmers in Asian countries, including Japan to India, further upsetting poultry prices. Since November 2020, more than 20 million chickens have been destroyed in South Korea and Japan.

The growing demand for healthy chicken food in Europe, the Middle East & Africa (EMEA) encourages governments to create suitable laws and regulations for the safety of animals in the poultry business. For example, infections with Campylobacter and Salmonella species are the two most common foodborne illnesses caused by eating chicken meat. The instances of influenza H5N1 infection in humans are linked to the consumption of raw or undercooked chicken or chicken products (HPAI). Based on demands, there has been a rise in the production of poultry products in the EMEA. With the rise in demand for poultry food products, the need for vaccines is on the rise to keep poultry safe and achieve optimum yields. However, the demand is decreasing in the poorer African countries. Poultry birds are susceptible to various fowl illnesses, which cause significant economic losses to the business, particularly in poorer nations.

Key Topics Covered:

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Poultry Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Poultry Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Diseases in Poultry
5.1.2 Increasing Demand for Healthy Poultry Food
5.2 Market Restraints
5.2.1 Failure of Vaccines in Poultry Production
5.3 Market Opportunities
5.3.1 Rising Growth of Market in Untapped Economies
5.4 Future Trends
5.4.1 Key Business Strategies to Enhance Market Growth in Future
5.5 Impact Analysis

6. Poultry Vaccines Market - Global Analysis
6.1 Poultry Vaccines Market Revenue Forecast and Analysis
6.1.1 Poultry Vaccines Market Revenue Forecast and Analysis
6.1.2 Global Poultry Vaccines Market - Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Share Analysis of Key Players (2020)
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Merck
6.2.4.2 Boehringer Ingelheim

7. Poultry Vaccines Market Analysis - By Type
7.1 Overview
7.2 Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)
7.3 Broiler
7.3.1 Overview
7.3.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Layer
7.4.1 Overview
7.4.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Breeder
7.5.1 Overview
7.5.2 Breeder: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

8. Poultry Vaccines Market Analysis - By Technology
8.1 Overview
8.2 Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live attenuated vaccines: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Recombinant Vaccines
8.5.1 Overview
8.5.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

9. Poultry Vaccines Market Analysis - By Dosage Form
9.1 Overview
9.2 Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)
9.3 Liquid Vaccines
9.3.1 Overview
9.3.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Freeze-Dried Vaccines
9.4.1 Overview
9.4.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dust/Powdered Vaccines
9.5.1 Overview
9.5.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

10. Poultry Vaccines Market Analysis - By Disease
10.1 Overview
10.2 Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)
10.3 Infectious Bronchitis
10.3.1 Overview
10.3.2 Infectious Bronchitis: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Avian Influenza
10.4.1 Overview
10.4.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Marek's Disease
10.5.1 Overview
10.5.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Bursal Disease
10.6.1 Overview
10.6.2 Infectious Bursal Disease: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.7 Salmonellosis
10.7.1 Overview
10.7.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.8 Newcastle Disease
10.8.1 Overview
10.8.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

11. Poultry Vaccines Market Analysis - By Route of Administration
11.1 Overview
11.2 Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)
11.3 Drinking water (D/W) & Spray
11.3.1 Overview
11.3.2 Drinking water (D/W) & Spray: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.4 Intramuscular (I/M)
11.4.1 Overview
11.4.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.5 Subcutaneous (S/C)
11.5.1 Overview
11.5.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.6 Others
11.6.1 Overview
11.6.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

12. Poultry Vaccines Market Analysis - By End User
12.1 Overview
12.2 Poultry Vaccines Market Share, by End User, 2021 and 2028, (%)
12.3 Veterinary Hospitals
12.3.1 Overview
12.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.4 Poultry Vaccination Centers & Clinics
12.4.1 Overview
12.4.2 Poultry Vaccination Centre: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.5 Poultry Farms and Hatchery
12.5.1 Overview
12.5.2 Poultry Farms and Hatchery: Poultry Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

13. Global Poultry Vaccines Market - Geographic Analysis

14. Impact of COVID-19 Pandemic on Poultry Vaccines Market
14.1 North America: Impact Assessment of COVID-19 Pandemic
14.2 Europe: Impact Assessment of COVID-19 Pandemic
14.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
14.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
14.5 South and Central America: Impact Assessment of COVID-19 Pandemic

15. Poultry Vaccine Market - Industry Landscape
15.1 Overview
15.2 Growth Strategies in the Poultry Vaccine Market (%)
15.3 Organic Developments
15.3.1 Overview
15.4 Inorganic Developments
15.4.1 Overview

16. Company Profiles
16.1 Boehringer Ingelheim International GmbH
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Zoetis Inc.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva Sante Animale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 BIOVAC
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 PHIBRO ANIMAL HEALTH CORPORATION
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Hester Biosciences Limited
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Venky's India
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Dechra Pharmaceuticals PLC
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Elanco
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Merck Animal Health
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments

17. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/vxvwiy

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets